FindTrial
Sign In

To study the effects of a Unani formulation in patients with Psoriasis

Evaluating the therapeutic effects of Joshanda Aftimoon (Cuscuta reflexa) in the management of Taqashshur-al-Jild (Psoriasis) An open label, observational study.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050383
Enrollment
60
Registered
2023-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: Joshanda Aftimoon: It is a classical Unani formulation taken from Al Qarabateen. The formulation comprises of AFTIMOON (Cuscuta reflexa), POST HALEELA ZARD (Terminalia chebula Retz.), H

Sponsors

Central Council for Research in Unani Medicine New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed patients of psoriasis. 2. Patients of both genders. 3. Patients in the age group of 10-60 years. 4. Clinically stable patients.

Exclusion criteria

Exclusion criteria: 1. Childrens below 10 years. 2. Patients above 60 years. 3. Pregnant and lactating females. 4. Patients suffering from other concomitant diseases like dermatophytes, eczema, seborrheic dermatitis, Pityriasis Rosea. 5. Patients suffering from diabetes and malignancy.

Design outcomes

Primary

MeasureTime frame
1. Koebner phenomenon. 2. Ring of worn off. 3. Candle grease sign. 4. Oil drop sign. 5. KOH examination of skin scrap 6. Auzpitz sign. 7. Interleukin 17 and Interleukin 23. 8. Psoriasis Area Severity Index (PASI). 9. Dermatology Life Quality Index (DLQI) 10. Photos of lesion (Before and After)Timepoint: 90 Days—

Secondary

MeasureTime frame
1. Erythematous plaques. 2. Silvery scaling lesions. 3. Itching. 4. Visual Analog Scale (VAS). Timepoint: 90 Days—

Countries

India

Contacts

Public ContactDr Zaffar Hussain

Regional Research Institute of Unani Medicine (RRIUM) Srinagar

hussainzaffar6@gmail.com7006021996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026